|
|||||
|
|

Technology and consulting giant IBM (NYSE:IBM) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.7% year on year to $16.98 billion. On the other hand, next quarter’s revenue guidance of $15.72 billion was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $2.80 per share was 5.5% above analysts’ consensus estimates.
Is now the time to buy IBM? Find out in our full research report (it’s free).
IBM’s second-quarter results for 2025 were met with a negative market reaction despite the company exceeding Wall Street’s revenue and profit expectations. Management attributed the strong performance to ongoing momentum in its software and infrastructure segments, highlighting robust growth from Red Hat and the recent launch of its z17 mainframe. CEO Arvind Krishna noted that “demand remains high for technology that improves productivity, reduces costs and fuels innovation,” with AI and hybrid cloud solutions leading the way. Consulting, however, continued to face headwinds from a cautious demand environment, tempering overall results.
Looking ahead, IBM’s guidance reflects both optimism and caution. Management cited accelerating software growth, continued AI adoption, and new product launches as key drivers for the rest of 2025, while acknowledging ongoing macroeconomic uncertainty and slower consulting demand. CFO James Kavanaugh stated, “We remain laser-focused on driving efficiency and cost savings by leveraging technology and embedding AI in our workflows.” The company expects software and infrastructure to offset softer consulting performance, with productivity initiatives supporting margin expansion and cash flow targets.
Management credited double-digit software and infrastructure growth for the quarter’s outperformance, but acknowledged challenges in consulting and a dynamic demand environment.
IBM’s outlook centers on continued software and infrastructure expansion, ongoing AI adoption, and disciplined cost management, but tempered by consulting uncertainties and a mixed macroeconomic climate.
In future quarters, StockStory analysts will closely watch (1) the pace of AI-driven software adoption and recurring revenue growth, (2) the trajectory of infrastructure demand following new mainframe and Power platform launches, and (3) stabilization or reacceleration in consulting bookings and backlog quality. Execution on productivity initiatives and integration of recent acquisitions will also be key markers for IBM’s progress.
IBM currently trades at $260.58, down from $282.22 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
Donald Trump’s April 2024 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| 1 hour | |
| 1 hour | |
| 1 hour | |
| 2 hours | |
| 2 hours | |
| 2 hours | |
| 2 hours | |
| 2 hours | |
| 3 hours | |
| 3 hours |
Stock Market Today: Dow Falls, Nvidia Pops On China Chip Hopes; AI Stocks Test Entries (Live Coverage)
IBM
Investor's Business Daily
|
| 3 hours | |
| 4 hours | |
| 4 hours | |
| 5 hours | |
| 5 hours |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite